Table 2 Types of AEs in patients with HIV and concomitant CRC according to antiviral regimens (n = 66)
AEs | DTG/3TC/TDF (group I) n = 20 | DTG/ABT (group II) n = 24 | BIC/TAF/FTC (group III) n = 22 | P value | |||
|---|---|---|---|---|---|---|---|
Any grade | grade 3-5 | Any grade | Grade 3-5 | Any grade | Grade 3-5 | ||
Neutropenia | 19 | 1 | 21 | 1 | 16 | 1 | 0.129 |
Anemia | 4 | 0 | 3 | 1 | 7 | 0 | 0.284 |
Thrombocytopenia | 2 | 0 | 1 | 0 | 1 | 0 | 0.672 |
Peripheral neurotoxicity | 13 | 0 | 11 | 0 | 11 | 0 | 0.421 |
Fever | 1 | 0 | 1 | 0 | 0 | 0 | – |
Infection | 0 | 0 | 0 | 0 | 1 | 0 | – |
Hypersensitivity | 0 | 0 | 1 | 0 | 0 | 0 | – |
Liver function damage | 0 | 0 | 1 | 0 | 3 | 0 | – |
Renal Impairment | 1 | 0 | 1 | 0 | 0 | 0 | – |
Nausea | 20 | 1 | 24 | 0 | 22 | 1 | – |
Vomiting | 2 | 1 | 2 | 0 | 3 | 0 | 0.884 |
Diarrhea | 0 | 0 | 0 | 0 | 1 | 0 | – |
Impaired cardiac function | 0 | 0 | 2 | 0 | 0 | 0 | – |